Page last updated: 2024-11-02

pd 98059 and Leukemia, Large Granular Lymphocytic

pd 98059 has been researched along with Leukemia, Large Granular Lymphocytic in 1 studies

2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one: inhibits MAP kinase kinase (MEK) activity, p42 MAPK and p44 MAPK; structure in first source
2-(2-amino-3-methoxyphenyl)chromen-4-one : A member of the class of monomethoxyflavones that is 3'-methoxyflavone bearing an additional amino substituent at position 2'.

Leukemia, Large Granular Lymphocytic: A spectrum of disorders characterized by clonal expansions of the peripheral blood LYMPHOCYTE populations known as large granular lymphocytes which contain abundant cytoplasm and azurophilic granules. Subtypes develop from either CD3-negative NATURAL KILLER CELLS or CD3-positive T-CELLS. The clinical course of both subtypes can vary from spontaneous regression to progressive, malignant disease.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Mizutani, N1
Ito, H1
Hagiwara, K1
Kobayashi, M1
Hoshikawa, A1
Nishida, Y1
Takagi, A1
Kojima, T1
Suzuki, M1
Osawa, Y1
Ohnishi, K1
Daibata, M1
Murate, T1

Other Studies

1 other study available for pd 98059 and Leukemia, Large Granular Lymphocytic

ArticleYear
Involvement of KRAS G12A mutation in the IL-2-independent growth of a human T-LGL leukemia cell line, PLT-2.
    Nagoya journal of medical science, 2012, Volume: 74, Issue:3-4

    Topics: Calcium-Calmodulin-Dependent Protein Kinases; Cell Line, Tumor; Cell Proliferation; Flavonoids; Huma

2012